Metabolix Inc. (MBLX) Announces Quarterly Earnings Results
Metabolix Inc. (NASDAQ:MBLX) announced its earnings results on Wednesday. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.09. Metabolix had a negative net margin of 261.19% and a negative return on equity of 210.86%.
Shares of Metabolix (NASDAQ:MBLX) opened at 0.4501 on Friday. Metabolix has a one year low of $0.26 and a one year high of $2.70. The firm’s market capitalization is $12.53 million. The firm’s 50-day moving average is $0.47 and its 200 day moving average is $0.69.
In other news, major shareholder William P. Scully sold 165,000 shares of the business’s stock in a transaction dated Friday, September 9th. The stock was sold at an average price of $0.35, for a total transaction of $57,750.00. Following the sale, the insider now directly owns 3,066,666 shares in the company, valued at $1,073,333.10. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 13.70% of the company’s stock.
An institutional investor recently bought a new position in Metabolix stock. GMT Capital Corp purchased a new stake in Metabolix Inc. (NASDAQ:MBLX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 335,617 shares of the company’s stock, valued at approximately $279,000. GMT Capital Corp owned approximately 1.21% of Metabolix as of its most recent filing with the SEC. Hedge funds and other institutional investors own 13.53% of the company’s stock.
Metabolix Company Profile
Metabolix, Inc is an advanced biomaterials company. The Company operates through the business of developing and commercializing technologies for the production of polymers and chemicals in microbes and plants segment. The Company is focused on delivering solutions to the plastics industry. The Company has its operations in the microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science.
Receive News & Stock Ratings for Metabolix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metabolix Inc. and related stocks with our FREE daily email newsletter.